Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GALR2 | O43603 | 2/20 | 0.62 |
| ▸ | GALR1 | P47211 | 2/20 | 0.62 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.55 |
| ▸ | CALCA | P06881 | 2/20 | 0.53 |
| ▸ | GLP1R | P43220 | 8/20 | 0.53 |
| ▸ | GIPR | P48546 | 6/20 | 0.53 |
| ▸ | CCKBR | P32239 | 2/20 | 0.52 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30429667 | 0.91 | NMBR (0.60) | GALR2GALR1KISS1RCALCAGLP1R | |
| SCHEMBL30429251 | 0.91 | CALCA (0.62) | GALR2GALR1CALCAGLP1R | |
| SCHEMBL29973367 | 0.89 | CXCL8 (0.62) | GALR2GALR1GLP1RGIPRCXCL8 | |
| Galantide SCHEMBL31332196 | 0.89 | IL23R (0.62) | GALR2GALR1GLP1RGIPRCCKBR | |
| SCHEMBL29973046 | 0.88 | KISS1R (0.62) | KISS1RGLP1R | |
| SCHEMBL13613774 | 0.88 | GALR2 (0.59) | GALR2GALR1CALCAGLP1RGIPR | |
| SCHEMBL30041162 | 0.86 | CALCA (0.64) | GALR2GALR1KISS1RCALCAGLP1R | |
| SCHEMBL29972984 | 0.86 | NPY1R (0.65) | KISS1RCALCAGLP1RGIPRCXCL8 | |
| SCHEMBL29992945 | 0.86 | CALCA (0.59) | GALR2GALR1KISS1RCALCACXCL8 | |
| SCHEMBL31061583 | 0.86 | GALR2 (0.65) | GALR2GALR1GLP1RGIPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158115-A1 | GAL(1-15) AND ANALOGUES THEREOF FOR USE IN THE PREVENTION AND/OR TREATMENT OF ALCOHOL-RELATED EFFECTS AND DISORDERS | UNIVERSIDAD DE MÁLAGA (ES) | 2023-05-25 | — | — | US | claimed |